![](http://elea-en.com.vnct3013.avnam.net/wp-content/uploads/Crisplus.png)
Crisplus
Obesity peripheral action treatment. Indicated for the treatment and long-term control of patients with obesity and overweight.
Therapeutic Area
Obesity
Active Ingredient
Orlistat
Line
Cardiometabolism + Endocrinology
Pharmaceutical Forms
60 mg capsules x 30
60 mg capsules x 60
120 mg capsules x 30
120 mg capsules x60
![Descargar](http://elea-en.com.vnct3013.avnam.net/wp-content/themes/elea/img/arrow-blue.png)